Paperonium

Psychiatry · Mol Psychiatry · 2016

Summary: more of an enzyme in bipolar patients’ cerebellum. The paper’s own data: a third less.

The summary“higher” with bipolar disordersame as without the illnessIts own table0.804with illness, 1.227 withoutIts results and discussion“lower”, “lower”, “reduced”
The summary“higher” with bipolar disordersame as without the illnessIts own table0.804with illness,1.227 withoutIts results and discussion“lower”, “lower”, “reduced”

More or less enzyme with bipolar disorder? What each part of the paper says

The paper says

In brains examined after death, the paper measured IDH3A, an enzyme cells use to make energy, in the cerebellum (a brain region) of 15 people with bipolar disorder and 15 without. Its summary, the part most people read, says the bipolar group had “higher” levels.

Its own data show

The paper’s own table gives the average measured amount of IDH3A in the cerebellum: 0.804 in people with the illness, 1.227 in people without, about a third less (34.5%). The sections reporting and discussing the results say the same three times: “lower”, “lower”, “reduced”. Only the summary’s one word is reversed.

A paper’s summary is often the only part people read, so readers are told the opposite of what this study found. The flipped word even contradicts the paper’s own argument: that too little of this enzyme may help cause bipolar disorder, and that the enzyme could be a target for new treatments. We found no published correction.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis · Mol Psychiatry (2016) · doi:10.1038/mp.2015.217